Merck Updates Bellwave Clinical Development Program for Nemtabrutinib
Merck announced an update to the Bellwave clinical development program evaluating nemtabrutinib; no further details were provided.
Merck announced an update to the Bellwave clinical development program evaluating nemtabrutinib; no further details were provided.